Maybe Logo Early Access

Tools / Inside Trading Tracker

Inside Trading Tracker

Track insider trading activity at publicly traded companies to understand how executives are trading their shares.

    AbCellera Biologics Inc (ABCL) Insider Trading Activity

    Healthcare • Biotechnology • 586 employees

    AbCellera Biologics Inc. builds an engine for antibody drug discovery and development. Its engine discovers antibodies from natural immune responses, which are pre-enriched for antibodies. The company's preclinical products are ABCL635 for metabolic and endocrine conditions; and ABCL575 for atopic dermatitis. It has a research collaboration and license agreement with Eli Lilly and Company; a research collaboration with Confo Therapeutics for the discovery of therapeutic antibody candidates targeting two undisclosed GPCR targets; and strategic collaboration with Biogen Inc. to discover therapeutic antibodies for neurological conditions, as well as collaboration with Viking Global Investors and ArrowMark Partners. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.

    Total Value

    $1,043,051.76

    Total Shares

    395,766

    Average Trade Value

    $347,683.92

    Most Active Insider

    Thermopylae Holdings Ltd.

    Total Activity: $739,977

    Largest Single Transaction

    $739,977

    by Thermopylae Holdings Ltd. on Aug 29, 2024

    30-Day Activity

    0 Transactions

    Volume: 0 shares
    Value: $0

    Name
    Position
    Date
    Shares
    Value
    Holdings
    Type
    Chief Executive Officer
    Director, Officer, 10% Owner
    Nov 25, 2024 56,125 $151,538 898,000 (+6.3%) Exercise/Conversion
    Chief Executive Officer
    Director, Officer, 10% Owner
    Sep 20, 2024 56,125 $151,538 841,875 (+6.7%) Exercise/Conversion
    10% Owner
    Aug 29, 2024 283,516 $739,977 56,086,009 (+0.5%) Purchase